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Background: Long non-coding RNAs (lncRNAs) are prevalently transcribed in the genome yet their potential roles
in human cancers are not well understood. The aim of the present study was to determine the lncRNA expression
profile in gastric cancer and its potential clinical value.
Methods: The global lncRNA expression profile in gastric cancer was measured by lncRNA microarray. Levels of two
representative lncRNAs, H19 and uc001lsz, were confirmed by real-time reverse transcriptase-polymerase chain
reaction. The relationship between their levels and clinicopathological factors of patients with gastric cancer was
explored. A receiver operating characteristic (ROC) curve was constructed for differentiating gastric cancer from
benign gastric diseases.
Results: Total of 135 lncRNAs, which differential expression levels between tumor and non-tumorous tissues were
more than twofold, were found (GEO No. GSE47850). The most down-regulated lncRNAs in gastric cancer tissues
were FER1L4, uc001lsz, BG491697, AF131784, uc009ycs, BG981369, AF147447, HMlincRNA1600, and AK054588; while
the most up-regulated ones were H19, HMlincRNA717, BM709340, BQ213083, AK054978, and DB077273. H19 was
found highly expressed in stomach and liver cancer cell lines, while lowly expressed in lung cancer and prostate
cancer cell lines. Uc001lsz was lowly expressed in gastric, lung and liver cancer cell lines, while highly expressed in
prostate cancer. The areas under ROC curves were up to 0.613, 0.751, and 0.761 for H19, uc001lsz, and the
combination, respectively.
Conclusions: The lncRNA expression profile in gastric cancer suggests the potential roles of lncRNAs in gastric
cancer occurrence and development. The overexpression of H19 in gastric cancer suggests that H19 may be
participated in gastric cancer. The reduced expression of uc001lsz in gastric cancer cell lines and tissues, its
associations with TNM stage, and its dysregulation in early cancer and precancerous lesions suggest that uc001lsz
may be a potential marker for the diagnosis of early gastric cancer.
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The well-studied components in the human genome are
those of protein-coding genes. However, the coding exons
of these genes account for only 1.5% of the genome [1]. In
recent years, it has become increasingly apparent that the
non-protein-coding portion of the genome is of crucial
functional importance for disease occurrence [2]. The
non-coding RNAs (ncRNAs) characterize as three types,* Correspondence: guojunming@nbu.edu.cn
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reproduction in any medium, provided the orlong ncRNAs, mid-size ncRNAs and short ncRNAs [1].
Although most studies on ncRNAs are focused on short
ncRNAs, such as microRNAs (miRNAs), long non-coding
RNAs (lncRNAs) are rapidly gaining prominence recently.
LncRNAs are greater than 200 nucleotides in length [3].
They have emerged recently as major players in governing
fundamental biological processes. Aberrant expression of
lncRNAs has been associated with cancers [3]. For example,
Differential display code 3 (DD3PCA3), a prostate-specific
lncRNA, appears to be a marker for early diagnosis of pros-
tate cancer [4]. More important, DD3PCA3 can be detected
in urine from patients with prostate cancer [5]. Thoughtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(MALAT-1) is first found abnormal expressed in metasta-
sizing non-small-cell lung carcinomas [6], it is up-regulated
in hepatocarcinoma, breast cancer, pancreatic cancer, colo-
rectal cancer, and prostate cancer [7]. MALAT-1 is not only
a potential diagnostic marker, but also a potential prognos-
tic marker [8]. HOX transcript antisense RNA (HOTAIR)
is associated with breast cancer and colorectal cancer
[9,10]. H19, another famous lncRNA, is frequently in-
volved in pediatric and adult tumors [11].
Gastric cancer is still one of the most frequent causes
of mortality in the world [12]. However, traditional strat-
egies based on radical surgery for the treatment of gastric
cancer are not yet satisfactory. Therefore, reveal of the
mechanisms of occurrence and development of gastric
cancer is attracting increased attention in cancer research.
Since the global lncRNA expression profile in gastric
cancer is not fully uncovered, in the present study, we
explored the lncRNA expression profile in gastric cancer.
Then the relationship between the aberrantly expressed-
lncRNAs and clinicopathological factors of patients with
gastric cancer was explored. Our data provides candidate
diagnostic biomarkers of gastric cancer.
Methods
Patients and specimens
Gastric cancer patients’ tissues, including gastric cancer
tissues, precancerous lesion and corresponding adjacent
non-tumorous tissues were immediately preserved in
RNA fixer (Bioteke, Beijing, China) after removal from
the body and stored at –80°C until use. Tissue samples
were obtained from surgical or biopsy specimens from
February 2011 to June 2012 at three cancer centers,
Yinzhou People’s Hospital, Ningbo No. 1 Hospital and
The Affiliated Hospital of Ningbo University School of
Medicine, China. Informed consent was taken from all
subjects. The Human Research Ethics Committee of
Ningbo University approved all aspects of this study. Tu-
mors were staged according to the tumor-node-metasta-
sis (TNM) staging system of the International Union
Against Cancer (5th ed). Histological grade was assessed
following the National Comprehensive Cancer Network
(NCCN) clinical practice guideline of oncology (V.1.2011).
The non-tumorous tissues were 5 cm from the edge of the
tumor and there were no obvious tumor cells, as evaluated
by a pathologist. There was no radiotherapy, chemother-
apy, targeted therapy or Dendritic cell/Cytokine-induced
killer (DC/CIK) therapy prior to the upper gastrointestinal
endoscopy examination or operation.
Total RNA preparation
Total RNA was isolated using Trizol reagent (Invitrogen,
Karlsruhe, Germany) following the manufacturer’s in-
structions [13].LncRNA microarray assay
Three paired biopsy specimens were obtained from pa-
tients (55 y and male, 76 y and male, and 88 y and female)
with poorly or poorly-and-moderately differentiated gas-
tric cancer. Human lncRNA microarray was manufactured
in NimbleGen Hybridization System (Arraystar, Rockville,
MD). More than 23 000 lncRNAs were collected from the
authoritative data sources including National Center for
Biotechnology Information (NCBI) RefSeq, University of
California, Santa Cruz (UCSC), lncRNAs from literatures
and Ultra Conserved Regions (UCRs) [14]. Data was
extracted and normalized using NimbleScan v2.5 software
(Roche NimbleGen, Madison, WI). Further Data analysis
was performed using Agilent GeneSpring GX 11.5 soft-
ware (Agilent Technologies, Santa Clara, CA).
Cell culture
Human gastric epithelial cell line (GES-1), gastric cancer
cell lines (AGS, MGC-803, and SGC-7901), liver normal
cell line (HL-7702), hepatic carcinoma cell lines (HepG2
and SMMC-7721), fetal lung fibroblast cell line (HELF),
lung carcinoma cell line (A549), prostate epithelial cell
line (RWPE-1), and prostate carcinoma cell lines (Du-145
and PC-3) were obtained from the Shanghai Institute of
Biochemistry and Cell Biology, Chinese Academy of Sci-
ences (Shanghai, China). Cells were cultured in culture
flasks at 37°C in a humidified atmosphere of 5% CO2 [15].
qRT-PCR detection of H19 and uc001lsz
Real-time quantitative reverse transcription-polymerase
chain reaction (qRT-PCR) is the gold standard for data
verification. To verify the results of lncRNA microarray,
cDNA was generated using the GoScript Reverse Tran-
scription (RT) System (Promega, Madison, WI). Quanti-
tative polymerase chain reaction (qPCR) was achieved
by using the GoTaq qPCR Master Mix (Promega, Madison,
WI) on an Mx3005P real-time PCR System (Stratagene, La
Jolla, CA). The sequences of the PCR primers for H19,
uc001lsz, and β-actin were as follows: 5′-ACCAGCCACC
ACATCATC-3′ (sense) and 5′-TCAGAAACAAAGAGA
CAGAAGG-3′ (antisense) for H19; 5′-GACGGCACCTA
CTACACCTT-3′ (sense) and 5′-GCTGACCACCTTGTT
GTTGAA-3′ (antisense) for uc001lsz; 5′-AAGCCACCCC
ACTTCTCTCTAA-3′ (sense) and 5′-AATGCTATCACC
TCCCCTGTGT-3′ (antisense) for β-actin. The data were
analyzed by the ΔCt method [16,17]. All results were
expressed as the Means ± SD of three independent
experiments.
Cloning and sequencing of qRT-PCR products
The qRT-PCR products of lncRNA were first purified
using a UNIQ-10 PCR Product Purification Kit and then
cloned into the pUCm-T vector (Sangon Biotech, Shanghai,
China) following the manufacturer’s instructions. Then,
Figure 1 Alterations in lncRNA expression profiles between
gastric carcinoma tissues and non-tumorous tissues. The result
from Hierarchical Clustering shows distinguishable lncRNA
expression profiling among samples. “Red” indicates high relative
expression; and “blue” indicates low relative expression.
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Co., Ltd.
Serological tumor marker analysis
Serum carcinoembryonic antigen (CEA) and carbohydrate
antigen 19-9 (CA19-9) were measured using an Elecsys
2010 machine (Roche Diagnostics, Basel, Switzerland).
The cutoff values were 5 ng/mL and 35 U/mL for CEA
and CA19-9, respectively.
Statistical analysis
All statistical data were analyzed by Statistical Program
for Social Sciences (SPSS) 18.0 software (SPSS, Chicago,
IL) and GraphPad Prism 6.0 (GraphPad Software, La
Jolla, CA). One way analysis of variance test, two-tailed
Student’s t-test and rank-sum test were used as appro-
priate. A receiver operating characteristic (ROC) curve
was established to evaluate the diagnostic value. P < 0.05
was considered statistically significant.
Results
LncRNA expression profiles in gastric cancer tissues
relative to adjacent non-tumorous tissues
The lncRNA expression patterns between gastric cancer
tissues and adjacent non-tumorous tissues were found to
be significantly different (Figure 1). Total of 135 lncRNAs,
which expression change was more than twofold, were found
(GEO accession numbers is 47850; http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE47850). Among them, 71 and
64 were up and down expressed in tumor tissues, respect-
ively. The most down-regulated lncRNAs in gastric cancer
tissues were FER1L4, uc001lsz, BG491697, AF131784,
uc009ycs, BG981369, AF147447, HMlincRNA1600, and
AK054588. The most up-regulated lncRNAs in gastric
cancer tissues were H19, HMlincRNA717, AI769947,
BQ213083, AK054978, and DB077273 (Table 1).
Expression of H19 was up-regulated in gastric carcinoma
tissues
Since H19 was found the most up-regulated lncRNA in
gastric cancer tissue, up to 8.91-fold change in micro-
array detection (Table 1), to validate this result, we
detected the expression level of H19 in two types of can-
cer tissues, biopsy tissues and surgical specimens, by
qRT-PCR. First, we explored the expression level of H19
in 15 pairs of gastric carcinoma’ biopsy tissues. We
found that its level in cancer tissues was significantly
higher than that in non-tumorous tissues (Figure 2A).
Then we detected H19 level in large number of surgical
specimens. As shown in Figure 2B, it was up-regulated
in 74.0% (57/77) of gastric cancer tissues (P = 0.029). By
sequencing the qRT-PCR product, we found that the se-
quence of H19 (Figure 2C) was consistent with that from
the database (http://www.ncbi.nlm.nih.gov/gene/283120).Expression of H19 in common cancer cell lines
To obtain more information about H19 expression in
cancers, we investigated its level in some common can-
cer cell lines. As shown in Figure 2D, comparing with
respective normal cell line, H19 was found highly
expressed in stomach cancer cell lines (AGS, MGC-803
and SGC-7901) and hepatocellular carcinoma cell lines
(SMMC-7721 and HepG2), while lowly expressed in
lung cancer cell line (A549) and prostate cancer cell
lines (Du-145 and PC-3).
Expression of uc001lsz was down-regulated in gastric
carcinoma tissues
Uc001lsz is a new-found lncRNA, which is transcribed
from the forward strand in chromosome 11p15.5. From
the microarray results (Table 1), we can see that
uc001lsz was the second most down-regulated lncRNA
Table 1 More than fourfold differentially expressed lncRNAs in gastric cancer tissues comparing with paired
non-tumorous tissues
Name Chromosome Regulation Fold change Sourcea P value
H19 11 up 8.91 lncRNAdb 0.020
HMlincRNA717 18 up 5.96 lincRNA 0.013
AI769947 7 up 5.51 lincRNA 0.026
BQ213083 2 up 5.45 lincRNA 0.040
AK054978 X up 4.59 lincRNA 0.006
DB077273 2 up 4.11 lincRNA 0.008
FER1L4 20 down 9.17 refNR 0.047
uc0 01lsz 11 down 8.36 UCSC_knowngene 0.020
BG491697 20 down 6.50 lincRNA 0.035
AF131784 18 down 6.25 mRNA 0.019
uc009ycs 11 down 5.82 UCSC_knowngene 0.009
BG981369 1 down 5.20 lincRNA 0.048
AF147447 16 down 4.76 mRNA 0.038
HMlincRNA1600 X down 4.12 lincRNA 0.013
AK054588 1 down 4.04 lincRNA 0.045
alncRNAdb: http://lncrnadb.com/Default.aspx; lincRNA: http://genome.ucsc.edu/cgi-bin/hgGateway; refNR: http://genome.ucsc.edu/cgi-bin/hgTables; www.ncbi.nlm.
nih.gov/RefSeq/; UCSC_knowngene: http://genome.ucsc.edu/cgi-bin/hgTables; mRNA: http://genome.ucsc.edu/cgi-bin/hgTables.
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us to further study uc001lsz was that it is trans associ-
ated with MUC2, which is secreted and forms an insoluble
mucous barrier in the gut lumen. To further validate the
expression of uc001lsz in gastric cancer, we expanded the
sample number. The data indicate that it was significantly
down-regulated in 84.4% (65/77) of gastric cancer tissues
(Figure 3A, P < 0.001). By sequencing the qRT-PCR prod-
uct, we found that the sequence of uc001lsz (Figure 3B)
was consistent with that from the database (http://genome.
ucsc.edu/cgi-bin/hgTables).
Expression of uc001lsz in common cancer cell lines
To obtain the expression information about uc001lsz in
common cancers, we detected its level in several com-
mon cancer cell lines. We found that comparing with re-
spective normal cell line, uc001lsz was lowly expressed
in gastric cancer (AGS, MGC-803 and SGC-7901), lung
cancer (A549) and liver cancer (SMMC-7721 and HepG2)
cell lines, while only highly expressed in prostate cancer
(Du-145 and PC-3) cell lines (Figure 3C).
Potential diagnostic values of H19 and uc001lsz
We next performed an analysis to identify whether H19
or uc001lsz expression was associated with the clinico-
pathological features of gastric cancer. As shown in
Table 2, the level of uc001lsz was associated with TNM
stages (P = 0.032). The positive detection rates of H19
and uc001lsz are 74.0% and 84.4%, respectively. Both of
them are higher than those of common gastric cancer
biomarker CEA (64.0%) and CA19-9 (53.3%) (Table 2).The areas under ROC curves were up to 0.613, 0.751,
and 0.761 for H19, uc001lsz, and the combination, re-
spectively (Figure 4). The combinative use of H19 and
uc001lsz slightly increased the diagnostic value.
Expression of uc001lsz was aberrant in early cancer and
precancerous lesions
At last, to observe the possible early diagnostic values of
lncRNA, we measured the level of uc001lsz in early can-
cer and precancerous lesions. We found that its level
was remarkable lower in these lesions compared with
those of corresponding adjacent non-tumorous tissues
(Figure 5A). The level of uc001lsz in normal tissues was
significantly higher than that in precancerous lesions
and early cancer tissues. Besides, its level in precancer-
ous lesions was conspicuous higher than that in early
cancer tissues (Figure 5B).
Discussion
Studies have shown that ~18% of the protein coding
genes that produce lncRNAs are associated with cancer,
whereas only 9% of all human protein coding genes are
associated with cancer [18]. The relationship between
lncRNAs and tumors has currently become one of the
focuses of cancer studies.
There is mounting evidence that lncRNAs are relation
to digestive system tumors [19]. Three lncRNAs, H19,
HOTAIR and lncRNA highly upregulated in liver cancer
(HULC), were found overexpression in human hepato-
cellular carcinomas (HCC) [20-22]. In addition, HULC
expression is not only confined to HCC, but is also
Figure 2 H19 was up-regulated in gastric cancer tissues, gastric cancer cell lines and other common cancer cell lines. Real-time qRT-PCR
was used to determine the expression level of H19. The ΔCt value was determined by subtracting the β-actin Ct value from the target lncRNA Ct
value. Smaller ΔCt value indicates higher expression. Level of H19 in gastric cancer biopsy tissues (n = 15, P = 0.014; A) and gastric cancer tissues
(n = 77, P = 0.029; B). Sequencing result of qRT-PCR product of H19 (C). The level of H19 in gastric cancer cell lines (AGS, MGC-803 and SGC-7901)
and liver cancer cell lines (SMMC-7721 and HepG2) was higher than that in human gastric epithelial cell line GES-1 and human liver normal cell
line HL-7702, respectively; however, its level in lung cancer cell line A549 and prostate cancer cell lines (Du-145 and PC-3) was lower than that in
human fetal lung fibroblast cell line HELF cells and human prostate epithelial cell line RWPE-1 (D). All results were expressed as the Means ± SD
of three independent experiments. #P < 0.001.
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the liver [23].
Researches about lncRNAs related to stomach are lim-
ited. Sun et al. found that the expression level of gastriccancer-associated transcript 1 (GACAT1), or AC096655.1-
002, was significantly correlated with lymph node metasta-
sis, distant metastasis, TNM stages, and differentiation
[17]. Mei et al. reported that ubiquitin-like modifier
Figure 3 Uc001lsz was down-regulated in gastric cancer tissues, gastric cancer cell lines and other common cancer cell lines. Real-time
qRT-PCR was used to determine the expression level of uc001lsz. Three independent experiments were performed. Level of uc001lsz in gastric
cancer tissues was significantly lower than that in corresponding non-tumorous tissues (n = 77, P < 0.001; A). Sequencing result of qRT-PCR
product of uc001lsz (B). The level of uc001lsz in gastric cancer cell lines (AGS, MGC-803 and SGC-7901), liver cancer cell lines (SMMC-7721 and
HepG2) and lung cancer cell line A549 was lower than that in human gastric epithelial cell line GES-1, human liver normal cell line HL-7702 and
human fetal lung fibroblast cell line HELF, respectively; however, its level in prostate cancer cell lines (Du-145 and PC-3) was higher than that in
human prostate epithelial cell line RWPE-1 (C).
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biomarker in the diagnosis of gastric cancer [16]. Niinuma
et al. found that overexpression of HOTAIR was markedly
associated with high-risk gastrointestinal stromal tumors
[24]. RNA, 7SK small nuclear (RN7SK) can indirectly
regulate gastric tumorigenesis via positive transcription
elongation factor-b (p-TEFb) [25]. H19 may play an im-
portant role in gastric cancer by loss of imprinting and
other mechanisms [26,27]. Recent, Cao et al. used bio-
informatics methods to screen lncRNA expression profiles
associated with gastric cancer [28]. First, two publicly
available human exon arrays for gastric cancer and data
for the corresponding normal tissue were downloaded
from the GEO. Then, the probes of the human exon arrayswere re-annotated. Finally, the probes uniquely mapping
to lncRNAs at the gene level were retained. Total of 88
lncRNAs that were differentially expressed in gastric cancer
were identified [28].
Here, the approaches for the screening of gastric can-
cer–associated lncRNAs were different from those used by
Cao et al. [28]. To identify the remarkably down-regulated
or up-regulated lncRNAs in gastric cancer, we first col-
lected gastric cancer and adjacent non-tumorous tissue
samples from upper gastrointestinal endoscopy examin-
ation. From the lncRNA expression profiles obtained from
lncRNA microarray analysis (Figure 1), we found that
among the significantly different expressed lncRNAs
(Table 1), only H19 has been found in other cancers
Table 2 The relationship of H19 and uc001lsz expression levels (ΔCt) in cancer tissues with clinicopathological factors
of patients with gastric cancera
Characteristics No. of patients (%) H19 uc001lsz
Mean ± SD P value Mean ± SD P value
Age (y)
≥ 60 59 (76.6) 8.74 ± 4.67 0.588 18.85 ± 4.94 0.240
< 60 18 (23.4) 8.08 ± 3.99 17.28 ± 4.85
Gender
Male 57 (74.0) 8.66 ± 4.81 0.823 18.19 ± 5.01 0.355
Female 20 (26.0) 8.40 ± 3.44 19.37 ± 4.58
Diameter (cm)b
≥ 5 39 (52.0) 7.98 ± 4.44 0.282 18.49 ± 5.03 0.682
< 5 36 (48.0) 9.10 ± 4.53 18.01 ± 5.11
CEAb
Positive 48 (64.0) 8.45 ± 4.21 0.882 18.28 ± 4.54 0.593
Negative 27 (36.0) 8.61 ± 5.01 18.92 ± 5.71
CA19-9b
Positive 40 (53.3) 8.68 ± 3.87 0.720 18.65 ± 4.64 0.792
Negative 35 (46.7) 8.31 ± 5.14 18.35 ± 5.37
Differentiationc
Well 3 (4.9) 8.28 ± 1.92 0.635 15.34 ± 5.40 0.371
Moderate 33 (54.1) 9.05 ± 4.40 19.37 ± 4.85
Poor 25 (41.0) 7.84 ± 5.47 19.54 ± 4.91
Lymphatic metastasisc
N0 20 (32.8) 8.95 ± 3.17 0.926 18.55 ± 6.01 0.472
N1&N2&N3 41 (67.2) 9.07 ± 5.25 19.53 ± 4.39
Distal metastasisc
M0 58 (95.1) 8.87 ± 4.70 0.258 19.13 ± 5.02 0.617
M1 3 (4.9) 12.00 ± 1.30 20.62 ± 3.74
Invasionc
Tis&T1-T3 20 (32.8) 10.04 ± 3.86 0.237 17.73 ± 4.72 0.105
T4 41 (67.2) 8.53 ± 4.95 19.93 ± 4.95
TNM stagec
0&I&II 24 (39.3) 9.40 ± 3.86 0.620 17.81 ± 5.52 0.032
III&IV 37 (60.7) 8.79 ± 5.14 20.49 ± 3.98
aAll samples are consist of 16 endoscopic biopsy samples and 61 surgery samples from patients with gastric cancer.
bNot detected for 2 patients who were performed endoscopy examination.
cOnly includes 61 surgery patients.
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clinical signatures of lncRNAs in the diagnosis and treat-
ment of gastric cancer.
The growing studies of functionally characterized lncRNAs
reveals that these transcripts are important in different
physiological processes, including embryonic stem cell dif-
ferentiation [29], T-cell differentiation [30], keratinocyte
differentiation [31], especially, the altered expression of
lncRNAs could result in cancer [32].In the present study, we focused on two lncRNAs,
H19 and uc001lsz. The expression level of H19 in gastric
cancer tissues was found to be evidently higher than that
in non-tumor tissues (Figure 2A and B). Together with
the increased expression of H19 in gastric cancer cell
lines (Figure 2D), we suggest that H19 may play an im-
portant role in gastric cancer pathogenesis. Interesting,
H19 expression is not increased in every types of tumor.
As showed in Figure 2D, H19 expression is decreased in
Figure 4 The ROC curve.
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ther certify that H19 acts not only as an oncogene but
also as a tumor suppressor [20,27,33]. Matouk et al.
found that the knocking-down of H19 RNA resulted in
nearly complete attenuation of p57kip2 induction in re-
sponse to hypoxic stress [20]. They further found that
H19 was associated with angiopoietin (ANG) and fibro-
blast growth factor-18 (FGF-18), whose functions are
involved in tumor growth and proliferation [20]. To
understand the molecular mechanism by which H19 in-
creases gastric cancer cell growth, Yang et al. examined
whether H19 affects the function of the tumor suppres-
sor p53 [27]. They found that H19 was associated withFigure 5 Expression of uc001lsz in early cancer and precancerous les
than that in paired normal tissue (n = 14, P = 0.0016; A). The level of uc001l
lesions and early cancers (B). #P < 0.001; *P < 0.05.p53, and that this association resulted in partial p53
inactivation [27].
Contrary to H19, uc001lsz expression level in gastric
cancer tissues was found to be markedly lower (Figure 3A).
As showed in Figure 3C, the expression of uc001lsz in
gastric cancer cell lines (AGS and MGC-803) is lower
than that in gastric epithelial cell (GES-1), but there was
no significant different between SGC-7901 and GES-1.
Maybe the low grade malignancy of SGC-7901 leads to
this result. More importantly, a greater association be-
tween uc001lsz expression and TNM stage was found
(Table 2). These results confirmed uc001lsz as an import-
ant player in inhibiting the development of gastric cancer.ions. The level of uc001lsz in early pathological change tissue is lower
sz in normal tissue is significantly higher than that in precancerous
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within protein-coding loci, which has strengthened the hy-
pothesis that lncRNAs may have cis-acting effects within
these loci. But uc001lsz may have trans-acting effect
within its adjacent protein-coding loci. MUC2, a member
of the mucin protein family of genes, is located next to
UC001LSZ. The MUC2 is secreted onto mucosal surfaces,
where it is secreted from goblet cells in the epithelial
lining into the lumen of the stomach [34]. As reported,
MUC2 was high expression in gastric cancer [35]. Al-
though uc001lsz seems playing as tumor suppressor gene
in gastric cancer and many other types of tumors, it may
play different role in prostate cancer where uc001lsz was
highly expressed (Figure 3C).
Molecular tumor biomarkers are vital diagnostic and
prognostic tools. Our data show that the expression of
uc001lsz was aberrant in early gastric cancer and gas-
tric precancerous lesions (Figure 5A). And the extraor-
dinary changes maybe appear in the precancerous lesions
(Figure 5B). This investigation indicates that uc001lsz may
be a candidate biomarker of gastric cancer.
Conclusions
In summary, we depict an lncRNA expression profile
that associated with gastric cancer. The overexpression
of H19 in gastric cancer cell lines and tissues suggests
that H19 may be participated in gastric cancer. The re-
duced expression of uc001lsz in gastric cancer cell lines
and tissues, its associations with TNM stage, and its
dysregulation in early cancer and precancerous lesions
suggest that uc001lsz may have an important role in gas-
tric cancer occurrence and be a potential biomarker for
the diagnosis of early gastric cancer.
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